C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
China · Delayed Price · Currency is CNY 5.25
+0.05 (0.96%)
Sep 30, 2026, 3:04 PM CST
SHE:000950 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | 358.9 | 386.72 | 282.99 | 624.63 | 952.28 | 1,005 |
Depreciation & Amortization | 415.11 | 460.89 | 465.72 | 396.81 | 403.9 | 312.62 |
Other Amortization | 76.52 | 73.86 | 76.8 | 48.52 | 33.17 | 37.51 |
Loss (Gain) From Sale of Assets | -7.31 | -4.63 | -10.53 | -0.79 | -10.05 | -3.52 |
Asset Writedown & Restructuring Costs | 30.88 | 31.69 | 40.21 | 20.49 | 27.93 | 10.67 |
Loss (Gain) From Sale of Investments | -492.74 | -412.41 | -409.33 | -317.71 | -305.8 | -429.57 |
Provision & Write-off of Bad Debts | 662.2 | 662.2 | 531.72 | 388.33 | 124.48 | 282.22 |
Other Operating Activities | 1,005 | 1,108 | 1,299 | 1,505 | 1,336 | 1,053 |
Change in Accounts Receivable | -2,852 | -2,800 | -1,663 | -5,316 | -3,878 | -3,989 |
Change in Inventory | 233.8 | -149.15 | -1,432 | -752.22 | -1,824 | -185.46 |
Change in Accounts Payable | -721.39 | 1,673 | 728.6 | 4,007 | 3,401 | 2,183 |
Operating Cash Flow | -581.27 | 754.67 | -186.74 | 508.53 | 285.83 | 250.16 |
Operating Cash Flow Growth | - | - | - | 77.92% | 14.26% | -60.42% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -351.38 | -299.54 | -250.53 | -244.41 | -268.07 | -489.55 |
Sale of Property, Plant & Equipment | 0.97 | 1.01 | 1.4 | 0.83 | 6.59 | 11.65 |
Cash Acquisitions | -8.67 | -25.2 | -109.33 | -187.75 | -226.86 | -650.59 |
Divestitures | 5.91 | 0.4 | - | -28.9 | 81.85 | 33.3 |
Investment in Securities | 339.42 | 339.42 | 41.04 | 68.49 | 168.16 | -39.84 |
Other Investing Activities | 172.11 | 119.04 | 95.9 | 24.94 | 47.09 | 165.52 |
Investing Cash Flow | 182.92 | 163.75 | -182.46 | -358.38 | -191.24 | -969.51 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 24,919 | 24,230 | 25,555 | 24,481 | 28,019 |
Long-Term Debt Repaid | - | -24,422 | -23,652 | -26,513 | -21,746 | -24,862 |
Lease Payments | -163.23 | -110.06 | -134.16 | -169.58 | -129.6 | -158.25 |
Net Debt Issued (Repaid) | 3,275 | 497.3 | 578.14 | -958.02 | 2,735 | 3,157 |
Issuance of Common Stock | - | - | - | - | - | 41.9 |
Common Dividends Paid | -781.54 | -873.57 | -1,120 | -1,299 | -928.81 | -1,227 |
Other Financing Activities | -609.59 | -578.16 | 590.28 | 2,510 | -626.11 | -429.17 |
Financing Cash Flow | 1,884 | -954.43 | 48.33 | 252.49 | 1,180 | 1,542 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | -0.12 |
Net Cash Flow | 1,486 | -36.02 | -320.87 | 402.64 | 1,274 | 822.74 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -932.65 | 455.13 | -437.27 | 264.13 | 17.76 | -239.38 |
Free Cash Flow Growth | - | - | - | 1386.93% | - | - |
Free Cash Flow Margin | -1.15% | 0.55% | -0.54% | 0.34% | 0.03% | -0.38% |
Free Cash Flow Per Share | -0.54 | 0.26 | -0.25 | 0.15 | 0.01 | -0.14 |
Levered Free Cash Flow | -2,875 | -1,301 | -1,389 | 1,225 | -2,481 | -3,830 |
Unlevered Free Cash Flow | -2,448 | -827.23 | -677.52 | 2,063 | -1,778 | -3,139 |
Free Cash Flow After Leases | -1,096 | 345.07 | -571.42 | 94.55 | -111.84 | -397.63 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 1,810 | 1,550 | 1,438 | 1,755 | 1,384 | 1,351 |
Change in Working Capital | -2,630 | -1,552 | -2,463 | -2,157 | -2,276 | -2,018 |